Dilasser F., Rose L., Quemener A., Ferrandez Y., Hassoun D., Rousselle M., Bergereau H., Marionneau Lambot S., Anselmino L.E., Trouillet C., Andre G., Maillasson M., Croyal M., Riviere M., Dubreuil D., Collet S., Souaze F., Campone M., Patsouris 2 A., Mortier E., Menacho Marquez M., Juin P., Lebreton J., Tessier A., Cherfils J., Loirand G., Sauzeau V., A Rac-specific competitive inhibitor of guanine nucleotide binding reduces metastasis in triple-negative breast cancer, Cell Reports Medicine, 2025, 6, 102233.
Dupas T., Vergnaud A., Pelé T., Blangy-Letheule A., Aillerie V., Bouaud M., Erraud A., Maillard A., Hassoun D., Persello A., Lecomte J., Rivière M., Tessier A., Leroux A.A., Rozec B., Denis M., Lauzier B, O-GlcNAcylation levels remain stable regardless of the anaesthesia in healthy rats, Scientific Reports, 2024, 14, 10669.
Rupérez D., Rivière M., Lebreton J., Aznar M., Silva F., Tessier A., Cariou R., Nerín C., Synthesis and quantification of oligoesters migrating from starch-based food packaging materials, Journal of Hazardous Materials, 2024, 476, 135202.
Foret-Lucas C., Figueroa T., Bertin A., Bessière P., Lucas L., Wasniewski M., Servat A., Tessier A., Lezoualc'h F*., Volmer R.*, EPAC1 pharmacological inhibition with AM-001 prevents SARS-CoV-2 and influenza A virus replication in cells, Viruses, 2023, 15, 319.
Lagneau N., Tournier P., Helesbeux J-J., Halgand B., Loll F., Garnier C., Jonchère C., Rivière M., Lebreton J., Tessier A., Maugars Y., Guicheux J., Le Visage C., Delplace V., A New Boronate Ester-Based Crosslinking Strategy Allows the Design of Nonswelling and Long-Term Stable Dynamic Covalent Hydrogels, Biomaterial Science, 2023, 11, 2033-2045.
Cariou R., Riviere M., Hutinet S., Tebbaa A., Dubreuil D., Mathé-Allainmat M., Lebreton J., LeBizec B., Tessier A., Dervilly G., Thorough investigation of non-volatile substances extractible from inner coatings of metallic cans and their occurrence in the canned vegetables, Journal of Hazardous Materials, 2022, 5, 129026.
Dupas T., Persello A., Blangy-Letheule A., Denis M., Erraud A., Aillerie V., Leroux A., Riviere M., Lebreton J., Tessier A., Rozec B., Lauzier B., Beneficial Effects of O-GlcNAc Stimulation in a Young Rat Model of Sepsis: Beyond Modulation of Gene Expression, International Journal of Molecular Sciences, 2022, 23, 6430.
Denis M., Dupas T., Persello A., Dontaine J., Bultot L., Betus C., Pelé T., Dhot J., Erraud A., Maillard A., Montnach J., Leroux A.A., Bigot-Corbel E., Vertommen D., Rivière M., Lebreton J., Tessier A., De Waard M., Bertrand L., Rozec B., Lauzier B., An O-GlcNAcylomic Approach Reveals ACLY as a Potential Target in Sepsis in the Young Rat, International Journal of Molecular Sciences, 2021, 22, 9236.
Patin J., Castro C., Steenman M., Hivonnait A., Carcouët A., Tessier A., Lebreton J., Bihouée A., Donnart A., Le Marec H., Baró I., Charpentier F., Derangeon M., Gap-134, a Connexin43 activator, prevents age-related development of ventricular fibrosis in Scn5a+/- mice, Pharmacological Research 2020, 159, 104922.
Vereshchuk N., Matheu R., Benet-Buchholz J., Pipelier M., Lebreton J., Dubreuil D., Tessier A., Gimbert-Suriñach C., Ertem M.Z., Llobet A, Powerful Evolving Ru Water Oxidation Catalysts Based on a New FAME Ligand Containing Phosphonic Groups, Journal of the American Chemical Society, 2020, 142, 5068-5077.
Gomez-Bougie P., Dousset C., Descamps G., Schnitzler A., Pellat-Deceunynck C., Amiot M., Audiger L., Tessier A., Dubreuil D., Lebreton J., The selectivity of Marinopyrrole A to induce apoptosis in MCL1(high) BCL2(low) expressing myeloma cells is related to its ability to impair protein translation, British Journal of Haematology, 2018, 180, 147–166.
Matheu R., Ertem M., Pipelier M., Lebreton J., Dubreuil D., Benet-Buchholz J., Sala X., Tessier A., Llobet A., The Role of Seven Coordination in Ru-catalyzed Water Oxidation, ACS Catalysis, 2018, 8, 2039-2048.
1-Oxo-1H-phenalene-2,3-dicarbonitrile Heteroaromatic Scaffold: Revised Structure and Mechanistic Studies. Lenk R., Tessier A., Lefranc P., Silvestre V., Planchat A., Blot V., Dubreuil D., Lebreton J., Journal of Organic Chemistry, 2014, 79, 9754-9761.
Demeyer A., Fonteneau L., Liennard M., Foyer C., Weigel P., Laurent A.D., Lebreton J., Fleury F., Mathé-Allainmat M., Synthesis and biological evaluation of DIDS analogues as efficient inhibitors of RAD51 involved in homologous recombination, Bioorganic & Medicinal Chemistry Letters, 2023, 87, 129261.
Quemener A., Maillasson M., Arzel L., Sicard B., Vomiandry R., Mortier E., Dubreuil D., Jacques Y., Lebreton J., Mathe-Allainmat M., Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization, Journal of Medicinal Chemistry, 2017, 60, 6249-6272.
Breiman A., López Robles M.D., de Carné Trécesson S., Echasserieau K., Bernardeau K., Drickamer K., Imberty A., Barillé-Nion S., Altare F., Le Pendu J., Carcinoma-associated fucosylated antigens are markers of the epithelial state and can contribute to cell adhesion through CLEC17A (Prolectin), Oncotarget, 2016, 7, 14064-14082.
Audfray A., Beldjoudi M., Breiman A., Hurbin A., Boos I., Unverzagt C., Bouras M., Lantuejoul S., Coll J.L., Varrot A., Le Pendu J., Busser B., Imberty A., A Recombinant Fungal Lectin for Labeling Truncated Glycans on Human Cancer Cells, PLoS ONE, 2015, 10, 1-22.
Lamora A., Talbot J., Bougras G., Amiaud J., Leduc M., Chesneau J., Taurelle J., Stresing V., Le Deley M.C., Heymann M.F., Heymann D., Redini F., Verrecchia F., Clinical Cancer Research 2014, 20, 5097–5112.
Inhibitors of RAC1 and uses thereof for treating cancers
V. SAUZEAU, G. LOIRAND, A. TESSIER, J. LEBRETON, A. QUEMENER.
European Patent No. 17305664.9 - 6th June 2017
Inhibitors of RAC1 and uses thereof for inducing bronchodilatation
V. SAUZEAU, G. LOIRAND, A. TESSIER, J. LEBRETON, A. QUEMENER.
European Patent No.17305662.3 - 6th June 2017
Preparation of oxophenalene compounds and their uses in therapy and material fields.
J. Lebreton, R. Lenk, D. Dubreuil, V. Silvestre, A. Planchat.
WO 2013128425 A1 20130906 (2013) - Université de Nantes.
A collaborative work in medicinal chemistry for antibacterial discovery with CHEM-symbiose,
as a devoted custom synthesis platform,
AntibioDEAL Days - 2026 – Rennes.
CHEM-Symbiose : une plate-forme pour la synthèse de molécules d’intérêt biologique,
GP2A, 2025, Nantes.
Les oligoesters contaminants des aliments : identification, synthèse et évaluation des risques,
Journée CEISAM - 2024 - Nantes.
Identification de substances non intentionnellement ajoutées (NIAS) issues de vernis de boîtes de conserves,
Gen2Bio - 2024 - Saint-Malo.
CEISAM Chemical Library,
CEISAM Post-doc day - 2023 - Nantes.
Le marquage isotopique de molécules : un atout pour la recherche académique interdisciplinaire,
Gen2Bio - 2020 - Brest.
Synthesis of non−classical alpha−amino−acids for protein functionalization
Synthetic Biology – Scientific day of Nantes University - 2019 - Nantes.
Contributions des plates-formes CHEM-Symbiose et IMPACT à la valorisation académique de « petites molécules » d’intérêt thérapeutique telles que les inhibiteurs d’interaction protéine-protéine
Gen2Bio - 2018 - Rennes.
Plateforme CHEM-Symbiose : un interlocuteur et un acteur de vos projets de synthèse à façon,
Journée scientifique ScanMAT - 2017 - Rennes.
La plate-forme CHEM-Symbiose,
Journée UFIP - 2016 - Nantes.
Plateforme CHEM-Symbiose,
Gen2Bio - 2014 - Saint-Malo.
Yamaguchi-Yonemitsu macrolactonization for the controlled synthesis of (labelled) oligoesters as non-intentionally added substances (NIAS) in vegetable-containing metallic cans,
ESOC, 2025, Copenhague, Danemark.
CHEM-Symbiose, a custom synthesis platform of organic compounds,
Congrès CEISAM, 2025, Nantes.
Identification, synthesis and investigation of non-intentionally added substances (NIAS) in vegetable-containing metallic cans,
Congrès CEISAM, 2025, Nantes.
A collaborative work in the field of medicinal chemistry with CHEM-symbiose, as a devoted custom synthesis platform,
GP2A, 2025, Nantes.
CHEM-Symbiose : A custom synthesis platform of organic compounds for chemical-biology program,
GDR ChemBio, 2025, Nantes.
CHEM-Symbiose : a custom synthesis platform of organic compounds for chemical biology programs,
Congrès SCF Chembio, 2024, Saclay.
Étude de standards moléculaires pour l’identification de substances non intentionnellement ajoutées (NIAS),
Gen2Bio, 2024, Saint-Malo.